It is not approved by the FDA for any medical purpose, and that single fact shapes how every honest vendor lists it
PG-102 also reduced -cell area compared with vehicle and showed a trend toward lower levels than semaglutide or tirzepatide, suggesting decreased glucagon production (Fig
Both triple and dual receptor agonists show similar enhancement of cAMP production in comparison to single GLP-1 receptor agonists [75]
Houshmand-Oeregaard A, Hansen NS, Hjort L, Kelstrup L, Broholm C, Mathiesen ER, et al
[3] Epitalon reduced the number of spontaneous tumors and the number of metastases in mice that did develop spontaneous tumors in an experiment on one-year-old female mice of the C3H/He inbred strain, and is speculated to have oncostatic and anti-metastatic properties